Reactogenicity, Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Investigational Supra-seasonal Universal Influenza Vaccines - Inactivated (SUIVs) (GSK3816302A) in Healthy Adults
收藏DataCite Commons2024-12-02 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00008278/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to assess the reactogenicity, safety and immunogenicity of
different formulations of GlaxoSmithKline (GSK) Biologicals' investigational supra-seasonal
universal influenza vaccines (SUIVs) (unadjuvanted or adjuvanted) in 18 to 39 year-old
healthy subjects. Subjects will be enrolled and vaccinated with one or 2 primary dose(s)
followed by a booster dose one year later.
提供机构：
Vivli
创建时间：
2022-07-18
